Compass Oncology — Vancouver, Washington

Compass Oncology is a clinical research site located in Vancouver, Washington, United States 98684.

Crixeo Health Trust Score: 74/100 (FAIR). This profile has not yet been claimed by the site owner.

Compass Oncology has participated in 6 clinical trials with 2 currently active.

Therapeutic areas: Nonsquamous Nonsmall Cell Neoplasm of Lung, Colorectal Cancer, Colorectal Neoplasms.

Sponsors: OncoMed Pharmaceuticals, Inc., NuCana plc, Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 74/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Compass Oncology?

Compass Oncology has a Crixeo Trust Score of 74/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Compass Oncology conducted?

Compass Oncology has 6 clinical trials on record, with 2 currently active. Their work covers Nonsquamous Nonsmall Cell Neoplasm of Lung, Colorectal Cancer, Colorectal Neoplasms.

Is Compass Oncology accredited by Crixeo Health?

Yes — Compass Oncology holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Compass Oncology?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.